The COVID-19 vaccine produced by Oxford-AstraZeneca uses chimpanzee adenoviral vectors (ChAdOx1) that contain the glycoprotein antigen (spike protein) gene from the SARS-CoV-2. Here, ART4 is linked to COVID-19.